India lags behind in terms of commercially-oriented innovation, R&D and discovery of drug modules Read more
PLI scheme to help India become Aatmanirbhar in APIs; boost investments in high-value generics: ICRA Read more
Pharma firms with approval for projects under PLI scheme should start production at the earliest: Gowda Read more